189 related articles for article (PubMed ID: 29969527)
1. Folate-producing lactic acid bacteria reduce inflammation in mice with induced intestinal mucositis.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
J Appl Microbiol; 2018 Nov; 125(5):1494-1501. PubMed ID: 29969527
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of 5-fluorouracil-induced intestinal mucositis by Streptococcus thermophilus ST4 in a mouse model.
Shen SR; Chen WJ; Chu HF; Wu SH; Wang YR; Shen TL
PLoS One; 2021; 16(7):e0253540. PubMed ID: 34310611
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of vitamin-producing and immunomodulatory lactic acid bacteria as a potential co-adjuvant for cancer therapy in a mouse model.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
J Appl Microbiol; 2021 Jun; 130(6):2063-2074. PubMed ID: 33128836
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of the riboflavin-overproducing strain Lactobacillus plantarum CRL2130 on intestinal mucositis in mice.
Levit R; Savoy de Giori G; de Moreno de LeBlanc A; LeBlanc JG
Nutrition; 2018 Oct; 54():165-172. PubMed ID: 29982144
[TBL] [Abstract][Full Text] [Related]
5. SCID/NOD mice model for 5-FU induced intestinal mucositis: Safety and effects of probiotics as therapy.
Huang L; Chiang Chiau JS; Cheng ML; Chan WT; Jiang CB; Chang SW; Yeung CY; Lee HC
Pediatr Neonatol; 2019 Jun; 60(3):252-260. PubMed ID: 30150027
[TBL] [Abstract][Full Text] [Related]
6. Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses.
Kato S; Hamouda N; Kano Y; Oikawa Y; Tanaka Y; Matsumoto K; Amagase K; Shimakawa M
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1017-1025. PubMed ID: 28590519
[TBL] [Abstract][Full Text] [Related]
7. Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent 5-Fluorouracil (5-FU).
Whitford EJ; Cummins AG; Butler RN; Prisciandaro LD; Fauser JK; Yazbeck R; Lawrence A; Cheah KY; Wright TH; Lymn KA; Howarth GS
Cancer Biol Ther; 2009 Mar; 8(6):505-11. PubMed ID: 22930839
[TBL] [Abstract][Full Text] [Related]
8. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice.
Justino PF; Melo LF; Nogueira AF; Morais CM; Mendes WO; Franco AX; Souza EP; Ribeiro RA; Souza MH; Soares PM
Cancer Chemother Pharmacol; 2015 Mar; 75(3):559-67. PubMed ID: 25572363
[TBL] [Abstract][Full Text] [Related]
9. Alteration of Gut Microbiota and Inflammatory Cytokine/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis.
Li HL; Lu L; Wang XS; Qin LY; Wang P; Qiu SP; Wu H; Huang F; Zhang BB; Shi HL; Wu XJ
Front Cell Infect Microbiol; 2017; 7():455. PubMed ID: 29124041
[TBL] [Abstract][Full Text] [Related]
10. Protective effect and potential mechanisms of Wei-Chang-An pill on high-dose 5-fluorouracil-induced intestinal mucositis in mice.
Chen Y; Zheng H; Zhang J; Wang L; Jin Z; Gao W
J Ethnopharmacol; 2016 Aug; 190():200-11. PubMed ID: 27240747
[TBL] [Abstract][Full Text] [Related]
11. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats.
Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J
Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
[TBL] [Abstract][Full Text] [Related]
13. Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU).
Whitford EJ; Cummins AG; Butler RN; Prisciandaro LD; Fauser JK; Yazbeck R; Lawrence A; Cheah KY; Wright TH; Lymn KA; Howarth GS
Cancer Biol Ther; 2009 Mar; 8(6):505-11. PubMed ID: 19305160
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
[TBL] [Abstract][Full Text] [Related]
15. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
[TBL] [Abstract][Full Text] [Related]
16. Effects of Supernatants from Escherichia coli Nissle 1917 and Faecalibacterium prausnitzii on Intestinal Epithelial Cells and a Rat Model of 5-Fluorouracil-Induced Mucositis.
Wang H; Jatmiko YD; Bastian SE; Mashtoub S; Howarth GS
Nutr Cancer; 2017; 69(2):307-318. PubMed ID: 28094590
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.
Yeung CY; Chan WT; Jiang CB; Cheng ML; Liu CY; Chang SW; Chiang Chiau JS; Lee HC
PLoS One; 2015; 10(9):e0138746. PubMed ID: 26406888
[TBL] [Abstract][Full Text] [Related]
18. A new animal model of intestinal mucositis induced by the combination of irinotecan and 5-fluorouracil in mice.
Pereira VB; Melo AT; Assis-Júnior EM; Wong DV; Brito GA; Almeida PR; Ribeiro RA; Lima-Júnior RC
Cancer Chemother Pharmacol; 2016 Feb; 77(2):323-32. PubMed ID: 26666645
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
[TBL] [Abstract][Full Text] [Related]
20. Effects of Streptococcus thermophilus TH-4 in a rat model of doxorubicin-induced mucositis.
Wang H; Brook CL; Whittaker AL; Lawrence A; Yazbeck R; Howarth GS
Scand J Gastroenterol; 2013 Aug; 48(8):959-68. PubMed ID: 23865592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
